Sector

Drug Delivery Technologies a growing market

The global controlled release drug delivery market is poised to grow at a CAGR of 9.26% from 2023 to 2032. Main drivers of expansion are:

Growing elderly population

with needs for easy-to-use and convenient medicines

Prolonged therapeutic impact

with reduced adverse side effects and variations in drug levels

Cost effective ways

to take medicines enabling flexibility and self-administration

Our Portfolio Focus: Depression

1 in 10 adults are actively prescribed antidepressants in the US

13% of adults aged 18 and over have used antidepressants in the past 30 days
7-8% of American adults had a major depressive episode in the past year (17.7 million adults)
Antidepressant use increased from 10.6% to 13.2% from 
2010-2020
About 14% of Americans taking antidepressant medication have done so for 10 years or longer

By the Numbers

There were 10 Billion extended release antidepressants sold globally in 2023. Spektus delivers improved formulations of established XR antidepressant drugs.